Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives

Overview of attention for article published in Therapeutics and Clinical Risk Management, November 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 31 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 3,496 followers.

#Rituximab for #AntineutrophilCytoplasmicAntibody-associated #vasculitis: https://t.co/6d7ztgfrV5

Reply Repost Favourite

Rituximab for ANCA associated vasculitis https://t.co/6o6w9UFTZ5

Reply Repost Favourite

Rituximab for ANCA associated vasculitis https://t.co/tBLM4PU1Dl

Reply Repost Favourite

Rituximab for ANCA associated vasculitis https://t.co/7sTYtjJqBE

Reply Repost Favourite